- Published
- Updated
Calling feedback “anonymous” should not imply that no one could ever identify its source. Small groups, detailed accounts or technical records can allow indirect recognition. The words used to describe confidentiality should match the actual information flow rather than an assumed level of protection.
Define the workflow
Confirm collected fields and technical information with the relevant owner. Explain who sees responses and whether an individual reply is possible. Do not present an anonymous form as the only route for a clinical safety concern; also provide an appropriate direct contact channel.
Worked example
For example, at a site with only two participants, an account naming a staff member and date may reveal the respondent. Staff describe real limits instead of promising absolute anonymity. Aggregate reports reduce unnecessary detail, and responses follow appropriate review rather than becoming an unauthorized individual pursuit list.
Practical checks
- Compare claims of anonymity with the actual fields and technical records collected.
- Explain whether individual follow-up is possible and identify the appropriate clinical contact route.
- Assess indirect identification through quotations and details when reporting on small groups.
Decision and boundaries
A good process lets someone understand the confidentiality conditions for giving feedback. Not asking for a name does not itself prove anonymity. Assign responsibility for preventing pressure after critical comments and maintain suitable access. If feedback reveals a safety matter, follow the necessary authorized assessment route rather than using the anonymous label as a reason to ignore it.
Frequently asked questions
- Is every form without a name field anonymous?
- No. Other fields, technical information and event details may permit recognition, so review the actual arrangements.
- Can an anonymous form provide clinical help?
- Show an appropriate direct healthcare contact route and explain that an anonymous response may not support individual follow-up.